Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Happiness Biotech Announced the Sales of Epidemic Prevention Products Have Exceeded RMB45 million 2020-05-07 20:00
VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update 2020-05-05 20:30
WuXi AppTec Reports Solid First-Quarter 2020 Results 2020-04-29 17:30
QBiotics commercialises first tigilanol tiglate pharmaceutical product with launch of STELFONTA® 2020-04-28 14:43
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma 2020-04-27 18:00
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies 2020-04-23 20:30
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody) 2020-04-23 08:00
Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virtual Support 2020-04-22 19:00
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 2020-04-20 23:00
Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma 2020-04-20 08:00
Nucleus Network's 10 Step Guide to conducting Clinical Trials during a time of uncertainty 2020-04-14 21:17
WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection 2020-04-14 08:00
Gracell to Present the First-in-human, Universal TruUCAR™ GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting 2020-04-13 21:00
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment 2020-04-10 11:39
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis 2020-04-09 15:14
Samsung Biologics named Champion in 2020 CMO Leadership Awards 2020-04-08 20:00
THE.WAVE.TALK raises US$2M 2020-04-07 20:30
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment 2020-04-06 08:00
Gracell Announces China NMPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia 2020-04-03 22:00
ImmuneMed's 'hzVSF,' Used for Treatment of COVID-19 Pneumonia Patients 2020-03-30 21:00
1 105 106 107 108 109 204